13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study

PIGA, Antonio Giulio;
2015-01-01

2015
62
8
1427
1436
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1545-5017
13-valent pneumococcal conjugate vaccine; 23-valent pneumococcal polysaccharide vaccine; Hydroxycarbamide; Immunogenicity; Safety; Sickle cell disease; Oncology; Pediatrics, Perinatology and Child Health; Hematology
De Montalembert, Mariane; Abboud, Miguel R.; Fiquet, Anne; Inati, Adlette; Lebensburger, Jeffrey D.; Kaddah, Normeen; Mokhtar, Galila; Piga, Antonio; Halasa, Natasha; Inusa, Baba; Rees, David C.; Heath, Paul T.; Telfer, Paul; Driscoll, Catherine; Al Hajjar, Sami; Tozzi, Alberto; Jiang, Qin; Emini, Emilio A.; Gruber, William C.; Gurtman, Alejandra; Scott, Daniel A.
File in questo prodotto:
File Dimensione Formato  
Piga_R1_13-valent.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 716.29 kB
Formato Adobe PDF
716.29 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1523112
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 25
social impact